Marker Therapeutics Inc (MRKR)

[Phantom Lord]

The reverse split in $TPIV ‘s current situation is 100% a good thing. Probably the best reason to effect an RS is to uplist. That is what is happening here with $TPIV. Being on the Nasdaq will bring more eyes to us which is always a good thing. You always hear of some institutional investors as having limits on price and exchanges as to where they can invest their money. As in no stocks under, let’s say for example, $3 and no stocks not listed on a national exchange. I don’t know enough about these limitations and I can guarantee you that they vary by institution but if this is indeed the case then with this uplisting we are now in a situation for more institutions to take positions. Obviously more goes into that then what exchange we trade on and what price we are trading at but at least we aren’t restricted by those two things now. Long term should be good for us being on a regulated exchange.

In the short term there is potential for a slight drop just from the negative opinions on reverse splits. Unfortunately people just assume that a reverse split is bad in any situation and don’t care to look further into the matter. Should we see a drop after the RS my opinion is that it will be very minimal. The reason any drop will be minimal is that we have some good trials up and running (the largest of which is fully funded), good products in the pipeline, good partnerships developed (one being the Mayo Clinic & the other being $AZN who is splitting costs, which is huge given that a lot of other “partnerships” and large pharma company is only supplying their drug.) and hopefully more partnerships developing and current partnerships strengthening. Obviously having Eastern Capital as a major shareholder is huge because they are holding about a 40% position in the company. The thing to keep in mind is with a reverse split the only things that change are share count and price. Nothing changes fundamentally and I feel some people lose sight of that.

Another thing to look at is share structure. Depending on the ratio of the split our float will be drastically reduced. This should allow for quicker moves when news hits. Basic supply and demand. With less shares available when demand hits price will rise faster.

I think John & Glynn have done a good job getting us to where we are but there is obviously a lot more work to be done. We are off to a great start with multiple trials up and running though and the orphan and fast track designations should help us there. I see no problems in their abilities to keep us on the right track.

I know you asked for pros & cons and this post has been mostly pros. That is personally because I see only one con which was touched on a little bit and that is people’s negative opinions that are rarely backed by fact or evidence but only off of their “previous experience” in reverse splits. Not all companies are equal and not all reverse splits are equal. You need to dig deeper into the situation’s each company was in prior to the reverse splits to really see why they went right, or wrong. I can point to a few examples from each side with supporting evidence but don’t want to stray off-topic.

For all reasons listed in this post $TPIV is in a good position now and will remain in a good position after the RS.